Concepedia

Iuliana Shapira

IS

22

Publications

2.2K

Citations

20

H-Index

2006

Active since

Affiliations

Hofstra University(Current)

SUNY Downstate Health Sciences University

Memorial Sloan Kettering Cancer Center

Dana-Farber Cancer Institute

University of North Carolina at Chapel Hill

Iuliana Shapira is an author at Hofstra University specializing in medicine, oncology, and radiation oncology.

ORCID

Top concepts

Publications per year

2006–2023

22

Publications

22

Adjuvant Paclitaxel and Trastuzumab for Node-Negative, HER2-Positive Breast Cancer

Sara M. Tolaney, William T. Barry, Chau T. Dang et al. · New England Journal of Medicine · 2015 · 731 citations · Full text

Seven-Year Follow-Up Analysis of Adjuvant Paclitaxel and Trastuzumab Trial for Node-Negative, Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer

Sara M. Tolaney, Hao Guo, Sònia Pernas et al. · Journal of Clinical Oncology · 2019 · 276 citations · Full text

Brief Report: Induction of sustained remission in recurrent catastrophic antiphospholipid syndrome via inhibition of terminal complement with eculizumab

Iuliana Shapira, Danieli Andrade, Steven L. Allen et al. · Arthritis & Rheumatism · 2012 · 195 citations

Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer: final 10-year analysis of the open-label, single-arm, phase 2 APT trial

Sara M. Tolaney, Paolo Tarantino, Noah Graham et al. · The Lancet Oncology · 2023 · 151 citations

, , +6

Transcription factors TFE3 and TFEB are critical for CD40 ligand expression and thymus-dependent humoral immunity

Chongmin Huan, Matthew L. Kelly, R. Steele et al. · Nature Immunology · 2006 · 92 citations · Full text

, , +12

Rows per page

1–5 of 22